IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v20y2023i4p3471-d1070285.html
   My bibliography  Save this article

The Role of Preoperative Chronic Statin Therapy in Heart Transplant Receipts—A Retrospective Single-Center Cohort Study

Author

Listed:
  • Dragos-Florin Baba

    (Emergency Institute for Cardiovascular Diseases and Transplantation, 540142 Targu Mures, Romania
    Department of Cell and Molecular Biology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540142 Targu Mures, Romania)

  • Horatiu Suciu

    (Emergency Institute for Cardiovascular Diseases and Transplantation, 540142 Targu Mures, Romania
    Department of Surgery, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540142 Targu Mures, Romania)

  • Calin Avram

    (Department of Medical Informatics and Biostatistics, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540142 Targu Mures, Romania)

  • Alina Danilesco

    (Department of Cell and Molecular Biology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540142 Targu Mures, Romania)

  • Diana Andreea Moldovan

    (Emergency Institute for Cardiovascular Diseases and Transplantation, 540142 Targu Mures, Romania)

  • Radu Catalin Rauta

    (Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540142 Targu Mures, Romania)

  • Laurentiu Huma

    (Emergency Institute for Cardiovascular Diseases and Transplantation, 540142 Targu Mures, Romania
    Department of Cell and Molecular Biology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540142 Targu Mures, Romania)

  • Ileana Anca Sin

    (Department of Cell and Molecular Biology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540142 Targu Mures, Romania)

Abstract

Background: Statin therapy has been proven to reduce the risk of cardiovascular events. The objective of our retrospective study was to investigate the relationship between preoperative chronic administration of statins to postoperative 2-month heart transplantation complications. Methods: A total number of 38 heart transplantation recipients from the Cardiovascular and Transplant Emergency Institute of Târgu Mureș between May 2014 and January 2021 were included in our study. Results: In logistic regression, we found a statistical significance between statin treatment and the presence of postoperative complications of any cause (OR: 0.06, 95% CI: 0.008–0.56; p = 0.0128), simultaneously presenting an elevated risk for early-postoperative acute kidney injury (AKI). From the statin group, atorvastatin therapy had a higher risk of type 2 diabetes mellitus (T2DM) development (OR: 29.73, 95% CI: 1.19–741.76; p = 0.0387) and AKI (OR: 29.73, 95% CI: 1.19–741.76; p = 0.0387). C-reactive protein (CRP), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-c) represented risk factors, atorvastatin administration being independently associated with lower CRP values. Conclusions: Chronic previous administration of statins represented a protective factor to the development of 2-month postoperative complications of any cause in heart transplant receipts.

Suggested Citation

  • Dragos-Florin Baba & Horatiu Suciu & Calin Avram & Alina Danilesco & Diana Andreea Moldovan & Radu Catalin Rauta & Laurentiu Huma & Ileana Anca Sin, 2023. "The Role of Preoperative Chronic Statin Therapy in Heart Transplant Receipts—A Retrospective Single-Center Cohort Study," IJERPH, MDPI, vol. 20(4), pages 1-13, February.
    • Handle: RePEc:gam:jijerp:v:20:y:2023:i:4:p:3471-:d:1070285
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/20/4/3471/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/20/4/3471/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Muaamar Al-Gobari & Hai-Ha Le & Mor Fall & François Gueyffier & Bernard Burnand, 2017. "No benefits of statins for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: A meta-analysis of randomized controlled trials," PLOS ONE, Public Library of Science, vol. 12(2), pages 1-24, February.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.

      Corrections

      All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:20:y:2023:i:4:p:3471-:d:1070285. See general information about how to correct material in RePEc.

      If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

      If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

      If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

      For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

      Please note that corrections may take a couple of weeks to filter through the various RePEc services.

      IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.